175 related articles for article (PubMed ID: 36060648)
1. Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Lung Cancer Based on Deep Learning.
Yang X; Hu X; Guo N
Comput Math Methods Med; 2022; 2022():6495301. PubMed ID: 36060648
[TBL] [Abstract][Full Text] [Related]
2. Identification of
Guo N
Transl Cancer Res; 2022 Aug; 11(8):2688-2699. PubMed ID: 36093519
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer.
Wu H; Liu A
J Int Med Res; 2021 Mar; 49(3):300060521996183. PubMed ID: 33730930
[TBL] [Abstract][Full Text] [Related]
4. High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma.
Zhang Y; Li S; Li F; Lv C; Yang QK
Biol Direct; 2021 May; 16(1):10. PubMed ID: 34053456
[TBL] [Abstract][Full Text] [Related]
5. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
6. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
7. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.
Zhang J; Liu Y; Li Q; Zuo L; Zhang B; Zhao F; Fan F; Luo S; Hu Y; Sun C
Carcinogenesis; 2023 May; 44(3):242-251. PubMed ID: 36999754
[TBL] [Abstract][Full Text] [Related]
8. ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
Cheng J; Fan YQ; Liu BH; Zhou H; Wang JM; Chen QX
Oncol Rep; 2020 Jan; 43(1):147-158. PubMed ID: 31789401
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
[TBL] [Abstract][Full Text] [Related]
10. LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.
Cui J; Wang Y; Tian X; Miao Y; Ma L; Zhang C; Xu X; Wang J; Fang W; Zhang X
Antioxid Redox Signal; 2023 Sep; 39(7-9):491-511. PubMed ID: 37166352
[No Abstract] [Full Text] [Related]
11. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.
Sun XJ; Xu GL
Med Sci Monit; 2017 Sep; 23():4343-4350. PubMed ID: 28887439
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
14. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage.
Zhou J; Tang J; Zhang C; Li G; Lin X; Liao S; Luo J; Yu G; Zheng F; Guo Z; Shao W; Hu H; Xu L; Wu S; Li H
Free Radic Biol Med; 2024 Aug; 220():271-287. PubMed ID: 38734267
[TBL] [Abstract][Full Text] [Related]
15. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
Jia B; Li J; Song Y; Luo C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
[TBL] [Abstract][Full Text] [Related]
16. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4.
Bao C; Zhang J; Xian SY; Chen F
Free Radic Res; 2021 Jul; 55(7):853-864. PubMed ID: 34323631
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
19. A prognostic model based on ferroptosis-related long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer.
Yi WW; Guo XQ; Xu Y; Liang B; Song P
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2591-2604. PubMed ID: 37013777
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4.
Ma LL; Liang L; Zhou D; Wang SW
Neoplasma; 2021 Jan; 68(1):165-173. PubMed ID: 33038905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
